Cargando…
Quantitative phosphoproteomic analysis reveals chemoresistance-related proteins and signaling pathways induced by rhIL-6 in human osteosarcoma cells
BACKGROUND: IL-6 plays a pivotal role in resistance to chemotherapeutics, including lobaplatin. However, the underlying mechanisms are still unclear. This study was to investigate the changes in phosphoproteins and their related signaling pathways in the process of IL-6-induced chemoresistance to lo...
Autores principales: | Zhang, Rui, Wang, Huan, Li, Erliang, Wu, Yonghong, Wen, Yanhua, Li, Chenyu, Liao, Bo, Ma, Qiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557500/ https://www.ncbi.nlm.nih.gov/pubmed/34717622 http://dx.doi.org/10.1186/s12935-021-02286-z |
Ejemplares similares
-
Protein and Signaling Pathway Responses to rhIL-6 Intervention Before Lobaplatin Treatment in Osteosarcoma Cells
por: Wang, Huan, et al.
Publicado: (2021) -
Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis
por: Moreland, Larry, et al.
Publicado: (2001) -
Identification of a Recombinant Human Interleukin-12 (rhIL-12) Fragment in Non-Reduced SDS-PAGE
por: Yu, Lei, et al.
Publicado: (2019) -
Clinical and Immunological Effects of rhIL-2 Therapy in Eastern Chinese Patients with Multidrug-resistant Tuberculosis
por: Tan, Qi, et al.
Publicado: (2017) -
A Randomized Controlled Study of rhTPO and rhIL-11 for the Prophylactic Treatment of Chemotherapy-Induced Thrombocytopenia in Non-Small Cell Lung Cancer
por: Xu, Yunhua, et al.
Publicado: (2018)